The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review
S Wu, Z Sun, Z Guo, P Li, Q Mao, Y Tang… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Blood-activating and stasis-transforming traditional
Chinese medicines (BAST) are a class of herbs that have the effect of dilating blood vessels …
Chinese medicines (BAST) are a class of herbs that have the effect of dilating blood vessels …
Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis
H Duan, J Li, J Ma, T Chen, H Zhang… - Frontiers in …, 2024 - frontiersin.org
Background Chondrosarcomas are common primary malignant bone tumors; however,
comprehensive bibliometric analysis in this field has not yet been conducted. Therefore, this …
comprehensive bibliometric analysis in this field has not yet been conducted. Therefore, this …
A review on the role of gamma-butyrobetaine hydroxylase 1 antisense RNA 1 in the carcinogenesis and tumor progression
J Hu, J Liu, S Zhou, H Luo - Cancer Cell International, 2023 - Springer
Gamma-butyrobetaine hydroxylase 1 antisense RNA 1 (BBOX1-AS1), located on human
chromosome 11 p14, emerges as a critical player in tumorigenesis with diverse oncogenic …
chromosome 11 p14, emerges as a critical player in tumorigenesis with diverse oncogenic …
Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer
I Alfaro, M Vega, C Romero, MP Garrido - Pharmaceuticals, 2023 - mdpi.com
Ovarian cancer (OC) is one of the most lethal gynecological malignancies. The use of
biological compounds such as non-coding RNAs (ncRNAs) is being considered as a …
biological compounds such as non-coding RNAs (ncRNAs) is being considered as a …
LINC00540 promotes sorafenib resistance and functions as a ceRNA for miR-4677-3p to regulate AKR1C2 in hepatocellular carcinoma
K Xu, X Wang, S Hu, J Tang, S Liu, H Chen, X Zhang… - Heliyon, 2024 - cell.com
Sorafenib resistance is one of the main causes of poor prognosis in patients with advanced
hepatocellular carcinoma (HCC). Long noncoding RNAs (lncRNAs) function as suppressors …
hepatocellular carcinoma (HCC). Long noncoding RNAs (lncRNAs) function as suppressors …
Oncogenic signaling pathways in carcinogenesis
J Austen, E Bronte - Journal of Carcinogenesis, 2023 - submissions.carcinogenesis.com
The aim of research into the complexities of oncogenic signaling pathways in
carcinogenesis is dynamic and continuing. The discovery of targeted medicines and …
carcinogenesis is dynamic and continuing. The discovery of targeted medicines and …
[HTML][HTML] Correlation of SNHG7 and BGL3 expression in patients with de novo acute myeloid leukemia; novel insights into lncRNA effect in PI3K signaling context in …
S Hassani, P Rostami, M Pourtavakol… - … and Biophysics Reports, 2024 - Elsevier
Background Acute myeloid leukemia (AML) has been identified as a top priority for
discovering a reliable biomarker for treatment improvement and patient outcome prediction …
discovering a reliable biomarker for treatment improvement and patient outcome prediction …
Long non-coding RNAs (lncRNAs) in cancer metastasis: Molecular interactions and possible therapeutic targets
M Hashemi, S Salimimoghadam… - NON-CODING RNA …, 2023 - World Scientific
Although numerous studies have been carried out to find a promising therapy for cancer, this
disease still remains one of the most incurable human disorders. However, the mortality of …
disease still remains one of the most incurable human disorders. However, the mortality of …